We are testing a new medication for individuals with relapsed or refractory B-cell malignancies. This study aims to find the best dose to ensure safety and effectiveness.
Health conditions and diseases that the clinical trial is designed to study and treat.
B-cell malignancies are a group of cancers that affect B-cells, a type of white blood cell. This includes conditions like chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and diffuse large B-cell lymphoma (DLBCL), which can be recurrent or refractory, meaning they return after treatment or do not respond to standard therapies.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.